These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 23240024
1. Prediction of recurrent venous thromboembolism by clot lysis time: a prospective cohort study. Traby L, Kollars M, Eischer L, Eichinger S, Kyrle PA. PLoS One; 2012; 7(12):e51447. PubMed ID: 23240024 [Abstract] [Full Text] [Related]
2. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism. Mrozinska S, Cieslik J, Broniatowska E, Malinowski KP, Undas A. J Thromb Haemost; 2019 Nov; 17(11):1912-1922. PubMed ID: 31323706 [Abstract] [Full Text] [Related]
4. Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception. Piróg M, Piwowarczyk S, Undas A. Dis Markers; 2019 Nov; 2019():4923535. PubMed ID: 31827635 [Abstract] [Full Text] [Related]
5. Unfavorably altered plasma clot properties in women with a HERDOO2 score equal to or greater than 2 and prediction of recurrent venous thromboembolism. Mrozińska S, Cieślik J, Broniatowska E, Undas A. Pol Arch Intern Med; 2018 Oct 31; 128(10):572-579. PubMed ID: 30113019 [Abstract] [Full Text] [Related]
6. Clinical outcomes and plasma clot permeability and lysability in patients with venous thromboembolism on rivaroxaban: a cohort study. Frączek P, Krzysztofik M, Stanisz A, Undas A. Pol Arch Intern Med; 2019 Jun 28; 129(6):377-385. PubMed ID: 31063157 [Abstract] [Full Text] [Related]
7. Fibrin clot properties in women heterozygous for factor V Leiden mutation: effects of oral contraceptives. Krzek M, Ciesla-Dul M, Zabczyk M, Undas A. Thromb Res; 2012 Oct 28; 130(4):e216-21. PubMed ID: 22940058 [Abstract] [Full Text] [Related]
11. The risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort study. Eischer L, Eichinger S, Kyrle PA. J Thromb Haemost; 2014 May 28; 12(5):635-40. PubMed ID: 24548536 [Abstract] [Full Text] [Related]
12. Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis. Meltzer ME, Lisman T, Doggen CJ, de Groot PG, Rosendaal FR. PLoS Med; 2008 May 06; 5(5):e97. PubMed ID: 18462012 [Abstract] [Full Text] [Related]
14. G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism. Miles JS, Miletich JP, Goldhaber SZ, Hennekens CH, Ridker PM. J Am Coll Cardiol; 2001 Jan 06; 37(1):215-8. PubMed ID: 11153741 [Abstract] [Full Text] [Related]
15. In Children with Provoked Venous Thromboembolism, Increasing Plasma Coagulability during the First 3 Months Postdiagnosis is Prognostic of Recurrence. Betensky M, Mueller MG, Amankwah EK, Goldenberg NA. Thromb Haemost; 2020 May 06; 120(5):823-831. PubMed ID: 32369853 [Abstract] [Full Text] [Related]
17. Recurrent venous thromboembolism patients form clots with lower elastic modulus than those formed by patients with non-recurrent disease. Baker SR, Zabczyk M, Macrae FL, Duval C, Undas A, Ariëns RAS. J Thromb Haemost; 2019 Apr 06; 17(4):618-626. PubMed ID: 30725502 [Abstract] [Full Text] [Related]